Dr. Y

Psychiatrist

Profile:
Graduated from the Faculty of Medicine, National University of Japan. Doctor of Medicine, Doctor of Philosophy.

Qualifications: 

  • Doctor of Philosophy
  • A designated physician of mental health.
  • Medical specialist & Medical Advisor in Psychiatry of The Japanese Society of Psychiatry and Neurology
  • Medical specialist & Medical Advisor of The Japanese Psychogeriatric Society
  • Certified occupational physicians of Japan Medical Association
  • Certificated Public Psychologist

Specialties:

  • Experienced track and field athlete. He participated in the Hakone Ekiden (The most popular intercollegiate long-distance road relay in Japan.) qualifying race twice while he was a university student. He is currently a father of two and spends his days looking after his children.

 

Articles

Psychiatry and the Potential of Digital Tools（Series ＃5）

2023/02/16

The Second Part: Brief Cognitive Function Assessment Scale in Middle Age and Beyond “The MCI Screen (Atama no Kenko Check)”

In the previous article, we provided an overview of “The MCI Screen (Atama no Kenko Check)” as a cognitive function scale is expected to detect mild cognitive impairment (MCI) at an early stage. In the second part of issue, Dr. Y, a psychiatrist, will explain the specifics of the system and examples of its use in clinical research.

Psychiatry and the Potential of Digital Tools（Series ＃4）

2023/02/01

The First Part: Brief Cognitive Function Assessment Scale in Middle Age and Beyond “The MCI Screen (Atama no Kenko Check)”

It is said that “prevention” of dementia is the key to early detection and intervention to delay the onset of the disease. The “The MCI Screen (Atama no Kenko Check),” a cognitive function scale for healthy people with no complaints of cognitive decline, is expected to be useful for the early detection of mild cognitive impairment (MCI). Dr. Y, a psychiatrist, will explain this assessment scale in detail.

A Clinical Doctor's Explanation of Health Tech in Asia (Series＃6）

2022/08/11

The Second Part: AI-Enabled Portable Arm Rehabilitation Robot, “H-MAN”

In the previous part, we introduced the AI-enabled portable arm rehabilitation robot “H-MAN” developed by the Singapore start-up Articares. In this part, we will take a closer look at "H-MAN" based on several research reports.

A Clinical Doctor's Explanation of Health Tech in Asia (Series＃5）

2022/07/14

The First Part: AI-Enabled Portable Arm Rehabilitation Robot, “H-MAN”

A Singapore-based start-up company, Articares, has developed a rehabilitation robot equipped with AI as a treatment device for the functional decline of the upper limbs following a stroke. The company's “H-MAN,” which performs rehabilitation through a gamified environment, will be explained by clinician writer, Doctor. Y.

Psychiatry and the Potential of Digital Tools（Series ＃3）

2021/09/24

Current Status of Digital Therapeutics for Mild Cognitive Impairment

The number of patients with Alzheimer's disease (AD) is increasing, and digital therapeutics (DTx) for AD treatment is the focus of much attention. In the U.S., there are some startups that are supported by colossal research funds for research on screening for mild cognitive impairment (MCI). Dr. Y will explain the future of MCI treatment and DTx from the perspective of an active psychiatrist.

Psychiatry and the Potential of Digital Tools（Series ＃2）

2021/08/06

Digital Screening for Cognitive Impairment

With the FDA approval of Aducanumab for the treatment of Alzheimer's disease, how will it affect future treatments? Dr. Y, a psychiatrist, explains his views on this issue, including expectations for digital therapeutics to identify mild cognitive impairment (MCI).

Psychiatry and the Potential of Digital Tools (Series #1)

2021/06/21

The Impact of Changes in the COVID19 Pandemic on Psychiatry

Expectations for digital tools
In this new series of columns, an psychiatrist in Japan talks about the potential of digital tools in psychiatry. In this first part of a series, we present the expectations for digital tools for psychiatry in the COVID-19 Pandemic.

Digital Health
U.S. eHealth Journal

Vol. 84 (Issued at 2023/３/14)

ジャーナル84号のトピックは、Aetion社 (RWE)、CytoReason社 (AI創薬)、Pear Therapeutics社 (PDTx)、Headspace Health社 (メンタルヘルスケア)、Tidepool (糖尿病ケア)、Akili Interactive社 (PDTx)、Amazon Pharmacy社 など

Most Popular

1位

Online Roundtable Discussion Among Clinical Doctors 【Part 6】

LSMIP Editorial Office
2位

Aevice Health Develops Wearable Stethoscopes for Chronic Respiratory Disease Patients

Kazunori Seto M.D.
3位

Alcoholism and the Development of Therapeutic Apps

Nanao Amano
4位

The First Part: Tapping into the Challenges of Diabetes and Lifestyle Management, Health2Sync

Natsu Ono M.D.
5位

Xenoma, Where Your Everyday Life Becomes Preventive Medicine

Dr. Shinpaku

Press Room

Placeholder